An investigation into the correlation between intraperitoneal teicoplanin concentrations and treatment outcomes in peritoneal dialysis-associated peritonitis

Peritoneal dialysis-associated peritonitis (PDAP) is a frequent complication of peritoneal dialysis. The guidelines from the International Society for Peritoneal Dialysis (ISPD) suggest administering teicoplanin through the peritoneal route to treat PDAP, but do not specify the ideal concentration f...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lulu Wang, Jiangqing Fan, Xuejie Chen, Wenpu Lei, Chunming Jiang, Hang Liu, Yun Yang, Jizhong Shen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-09-01
Edice:	Frontiers in Pharmacology
Témata:	peritoneal dialysis-associated peritonitis teicoplanin peritoneal dialysis effluent therapeutic drug monitoring individualized drug therapy
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1446774/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!